FDA Inspection 1018218 — Collagen Matrix Inc

Collagen Matrix Inc — FEI 3008817245

The FDA completed an inspection of Collagen Matrix Inc on Jul 18, 2017 in Oakland, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 18, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Oakland, NJ (United States)

Citations

IDCFRDescription
319021 CFR 820.30(g)Design validation acceptance criteria
342621 CFR 820.50(a)(1)Documented evaluation
369621 CFR 820.100(b)Documentation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.